SCHEMBL1383036

SCHEMBL1383036

COc1ccccc1-c1cc(C(=O)Nc2ccc(S(C)(=O)=O)cc2)c(C)n1Cc1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 5/20 0.48
POLB P06746 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
THRB P10828 1/20 0.44
IRAK4 Q9NWZ3 1/20 0.42
NR3C2 P08235 1/20 0.41
MCL1 Q07820 1/20 0.41
ALB P02768 1/20 0.41
HTR1A P08908 1/20 0.41
SLC6A2 P23975 1/20 0.41
PDE4A P27815 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2439581 0.81 NR3C2 (0.53) RXFP1POLBSMN1; SMN2HPGDKMT2A
SCHEMBL1384217 0.72 NR3C2 (0.56) SMN1; SMN2HPGDKMT2ANR3C2MCL1
SCHEMBL2441015 0.71 NR3C2 (0.54) POLBSMN1; SMN2KMT2ANR3C2ALB
SCHEMBL1382118 0.71 NR3C2 (0.56) POLBKMT2ANR3C2MCL1ALB
SCHEMBL1382211 0.69 NR3C2 (0.62) POLBKMT2AIRAK4NR3C2ALB
SCHEMBL1378799 0.69 NR3C2 (0.53) RXFP1POLBSMN1; SMN2HPGDKMT2A
SCHEMBL1380607 0.69 NR3C2 (0.73) POLBNR3C2ALBHTR1ASLC6A2
SCHEMBL6792646 0.69 LMNA (0.47) RXFP1POLBSMN1; SMN2ALBHTR1A
SCHEMBL1382718 0.69 NR3C2 (0.49) POLBSMN1; SMN2HPGDKMT2ANR3C2
SCHEMBL1382455 0.68 NR3C2 (0.51) RXFP1POLBSMN1; SMN2NR3C2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4703649-B2 2011-06-15 JP claimed
EP-1773768-A4 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS INC (US) 2008-08-06 EP claimed
EP-1773768-A2 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS Exelixis, Inc. (US) 2007-04-18 EP claimed
WO-2006012642-A2 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2006-02-02 WO claimed